相关实验视频
Updated: Jan 13, 2026

04:08
Metacarpal Small Incision for Carpal Tunnel Syndrome
Published on: April 5, 2024
1.2K
目前针对扩散性紧缩性巨细胞瘤的治疗策略:文献综述
Hannah Mosher1, Kristen Dean1, Gabrielle Meli1
1Department of Orthopaedic Surgery, University of Miami Miller School of Medicine, Miami, Florida.
JB & JS open access
|January 12, 2026
概括
扩散性紧缩性巨细胞瘤 (DTGCT) 治疗正在超越手术发展. 新的全身疗法,如CSF1受体抑制剂,提供更好的结果和生活质量,特别是与手术结合使用时.
科学领域:
- 整形外科 整形外科 整形外科
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 扩散性紧突巨细胞瘤 (DTGCT) 是一种局部具有攻击性的良性突瘤.
- 最初的症状包括关节疼痛,硬和胀.
- 传统的手术切除具有很高的复发率.
研究的目的:
- 审查关于DTGCT的当前文献.
- 专注于新的全身疗法及其与手术的结合.
- 讨论不断变化的治疗模式.
主要方法:
- 关于DTGCT病理生理学,分类,诊断和治疗的文献综合.
- 重点是新的全身疗法,特别是CSF1受体抑制剂.
- 综合手术和全身治疗方法的评估.
主要成果:
- DTGCT通常影响年轻到中年成人,女性占主导地位,通常在膝盖.
- 交叉切除术的复发率可以超过50%.
- 在约40%的患者中,CSF1受体抑制剂在缓解症状和减少瘤负担方面表现出有效性,改善生活质量,并可能有助于新辅助治疗.
结论:
- 仅仅是手术通常是不够的,因为高复发率.
- 系统疗法可以改善生活质量,但也存在风险.
- 将新辅助性CSF1R抑制与手术相结合可能会提供更好的结果.
- 专门中心的多学科护理是DTGCT管理的最佳方式.
相关概念视频
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
476
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
476
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
475
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
475

